Factor V Leiden 1691G > A mutation and the risk of recurrent pregnancy loss (RPL): systematic review and meta-analysis.

1691G > A mutation Factor V Leiden Meta-analysis Meta-regression Recurrent pregnancy loss

Journal

Thrombosis journal
ISSN: 1477-9560
Titre abrégé: Thromb J
Pays: England
ID NLM: 101170542

Informations de publication

Date de publication:
2020
Historique:
received: 12 01 2020
accepted: 20 05 2020
entrez: 30 6 2020
pubmed: 1 7 2020
medline: 1 7 2020
Statut: epublish

Résumé

Although numerous replication case-control studies have attempted to determine the association between Factor V Leiden (FVL) 1691G > A mutation and susceptibility to Recurrent pregnancy loss (RPL), there have been confliction among the results of various ethnic groups. To address this limitation, here we implemented first meta-analysis to provide with consistent conclusion of the association between FVL 1691G > A mutation and RPL risk. After a systematic literature search, pooled odds ratio (OR) and their corresponding 95% confidence interval (CI) were used to evaluate the strength of the association. Additionally, meta-regression analyses were performed to find potential source of heterogeneity. In this meta-analysis, 62 studies, containing 10,410 cases and 9406 controls, were included in quantitative analysis. Overall population analysis revealed a significant positive association in the dominant (OR = 2.15, 95% CI = 1.84-2.50, The FVL 1691G > A mutation and the risk of RPL confers a genetic contributing factor in increasing the risk of RPL, particularly in Iranians, except for South Americans.

Sections du résumé

BACKGROUND BACKGROUND
Although numerous replication case-control studies have attempted to determine the association between Factor V Leiden (FVL) 1691G > A mutation and susceptibility to Recurrent pregnancy loss (RPL), there have been confliction among the results of various ethnic groups. To address this limitation, here we implemented first meta-analysis to provide with consistent conclusion of the association between FVL 1691G > A mutation and RPL risk.
METHODS METHODS
After a systematic literature search, pooled odds ratio (OR) and their corresponding 95% confidence interval (CI) were used to evaluate the strength of the association. Additionally, meta-regression analyses were performed to find potential source of heterogeneity.
RESULTS RESULTS
In this meta-analysis, 62 studies, containing 10,410 cases and 9406 controls, were included in quantitative analysis. Overall population analysis revealed a significant positive association in the dominant (OR = 2.15, 95% CI = 1.84-2.50,
CONCLUSION CONCLUSIONS
The FVL 1691G > A mutation and the risk of RPL confers a genetic contributing factor in increasing the risk of RPL, particularly in Iranians, except for South Americans.

Identifiants

pubmed: 32595420
doi: 10.1186/s12959-020-00224-z
pii: 224
pmc: PMC7313225
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

11

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no competing interests.

Références

Obstet Gynecol Sci. 2019 May;62(3):179-182
pubmed: 31139594
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Clin Appl Thromb Hemost. 2018 Sep;24(6):894-900
pubmed: 29363996
Hum Reprod. 1999 Oct;14(10):2448-50
pubmed: 10527966
N Engl J Med. 1995 Apr 6;332(14):912-7
pubmed: 7877648
Am J Reprod Immunol. 2001 Aug;46(2):124-31
pubmed: 11506076
Dig Liver Dis. 2009 Oct;41(10):717-20
pubmed: 19395327
Genet Test Mol Biomarkers. 2012 Apr;16(4):279-86
pubmed: 22047507
Hum Reprod. 2000 Feb;15(2):458-62
pubmed: 10655323
Med Clin (Barc). 2019 Apr 5;152(7):249-254
pubmed: 29523337
Curr Opin Endocrinol Diabetes Obes. 2009 Dec;16(6):446-50
pubmed: 19779333
J Natl Cancer Inst. 1959 Apr;22(4):719-48
pubmed: 13655060
Am J Reprod Immunol. 2003 Jul;50(1):20-32
pubmed: 14506925
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Eur J Obstet Gynecol Reprod Biol. 2005 Apr 1;119(2):164-70
pubmed: 15808373
Clin Lab. 2007;53(5-6):309-14
pubmed: 17605406
Ginekol Pol. 2017;88(7):385-392
pubmed: 28819944
Arch Gynecol Obstet. 2011 Nov;284(5):1127-32
pubmed: 21259017
Genet Test Mol Biomarkers. 2009 Dec;13(6):861-5
pubmed: 19839754
Arch Gynecol Obstet. 2013 Feb;287(2):375-81
pubmed: 22990475
J Assist Reprod Genet. 2013 Oct;30(10):1353-9
pubmed: 23989998
J Obstet Gynaecol. 2014 Apr;34(3):229-34
pubmed: 24484533
Hum Reprod Update. 2002 Sep-Oct;8(5):463-81
pubmed: 12398226
Arch Gynecol Obstet. 2015 Mar;291(3):671-9
pubmed: 25193429
J Pak Med Assoc. 2005 Mar;55(3):104-8
pubmed: 15852745
J Obstet Gynaecol Res. 2012 Sep;38(9):1168-76
pubmed: 22540831
Clin Obstet Gynecol. 2010 Sep;53(3):700-9
pubmed: 20661054
Ginekol Pol. 2012 Aug;83(8):598-603
pubmed: 23342883
Blood Coagul Fibrinolysis. 2009 Mar;20(2):134-40
pubmed: 19786941
Am J Hematol. 2002 Dec;71(4):300-5
pubmed: 12447960
Eur J Epidemiol. 2010 Sep;25(9):603-5
pubmed: 20652370
Biometrics. 1994 Dec;50(4):1088-101
pubmed: 7786990
Maedica (Buchar). 2012 Sep;7(3):222-6
pubmed: 23400304
Am J Reprod Immunol. 2006 May;55(5):360-8
pubmed: 16635210
Am J Reprod Immunol. 2012 Mar;67(3):251-5
pubmed: 22103678
Genet Mol Res. 2016 Jul 15;15(3):
pubmed: 27525841
Clin Exp Obstet Gynecol. 2014;41(2):177-81
pubmed: 24779247
Geburtshilfe Frauenheilkd. 2019 Jul;79(7):697-704
pubmed: 31303657
Thromb Haemost. 1999 Apr;81(4):532-7
pubmed: 10235434
Thromb Haemost. 1999 Jul;82(1):6-9
pubmed: 10456445
Lancet. 2006 Aug 12;368(9535):601-11
pubmed: 16905025
J Thromb Thrombolysis. 2013 Feb;35(2):250-6
pubmed: 22918664
J Reprod Infertil. 2012 Apr;13(2):89-94
pubmed: 23926530
Med Glas (Zenica). 2018 Aug 1;15(2):158-163
pubmed: 29703881
J Matern Fetal Neonatal Med. 2016;29(8):1269-73
pubmed: 26135458
Am J Hematol. 2005 Sep;80(1):12-9
pubmed: 16138341
Fertil Steril. 2010 Sep;94(4):e61
pubmed: 20633877
Int J Prev Med. 2018 Feb 08;9:13
pubmed: 29541428
Acta Obstet Gynecol Scand. 2003 Oct;82(10):942-7
pubmed: 12956845
Trends Mol Med. 2007 Jul;13(7):310-7
pubmed: 17574920
Thromb Res. 2010 Aug;126(2):e78-82
pubmed: 20605623
Iran Biomed J. ;22(2):78-89
pubmed: 28734273
Fertil Steril. 2000 Nov;74(5):987-91
pubmed: 11056246
Syst Biol Reprod Med. 2018 Aug;64(4):274-282
pubmed: 29658346
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
BJOG. 2009 Jun;116(7):995-8
pubmed: 19522801
Am J Reprod Immunol. 2013 Dec;70(6):518-21
pubmed: 23795816
Psychol Methods. 2006 Jun;11(2):193-206
pubmed: 16784338
J Thromb Thrombolysis. 2015 May;39(4):481-8
pubmed: 25771983
Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):266-70
pubmed: 10634828
Genet Med. 2011 Jan;13(1):1-16
pubmed: 21116184
Bosn J Basic Med Sci. 2017 Nov 20;17(4):309-314
pubmed: 28488549
Hematology. 2011 Jan;16(1):59-63
pubmed: 21269570
Curr Opin Obstet Gynecol. 2012 Aug;24(4):229-34
pubmed: 22729089
Rev Obstet Gynecol. 2009 Spring;2(2):76-83
pubmed: 19609401
Clin Genet. 2017 Feb;91(2):265-284
pubmed: 27792840
Iran Red Crescent Med J. 2013 Dec;15(12):e13708
pubmed: 24693393
Ann Hematol. 2007 Oct;86(10):727-31
pubmed: 17572893
Thromb Res. 2004;114(5-6):409-14
pubmed: 15507271
BJOG. 2001 Dec;108(12):1251-4
pubmed: 11843387
Am J Reprod Immunol. 2007 Feb;57(2):133-41
pubmed: 17217367
Thrombosis. 2012;2012:367823
pubmed: 22577540
Iran J Reprod Med. 2013 Jan;11(1):61-4
pubmed: 24639694
Hum Fertil (Camb). 2014 Jun;17(2):99-105
pubmed: 24564524
Thromb Haemost. 1997 May;77(5):822-4
pubmed: 9184385
Clin Appl Thromb Hemost. 2008 Jan;14(1):102-4
pubmed: 18160599
J Chin Med Assoc. 2013 May;76(5):282-8
pubmed: 23683262
J Pak Med Assoc. 2015 Nov;65(11):1169-72
pubmed: 26564286
Blood. 1995 Mar 15;85(6):1504-8
pubmed: 7888671
Med Glas (Zenica). 2020 Feb 01;17(1):
pubmed: 31994856
Clin Obstet Gynecol. 2016 Sep;59(3):498-508
pubmed: 27414972
Eur J Obstet Gynecol Reprod Biol. 2005 Apr 1;119(2):185-8
pubmed: 15808377
Ann Intern Med. 1999 Apr 20;130(8):643-50
pubmed: 10215560
Clin Appl Thromb Hemost. 2015 May;21(4):365-72
pubmed: 24463599
Fertil Steril. 2003 May;79(5):1141-8
pubmed: 12738509
Genet Test Mol Biomarkers. 2010 Oct;14(5):593-7
pubmed: 20707730
Am J Reprod Immunol. 2008 Oct;60(4):325-32
pubmed: 18754836
N Engl J Med. 1994 Feb 24;330(8):517-22
pubmed: 8302317

Auteurs

Mohammad Masoud Eslami (MM)

Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, North Kargar Av, Tehran, 14117 Iran.

Majid Khalili (M)

Department of Basic sciences, Maragheh University of medical sciences, Maragheh, Iran.
Rahat Breach and Sleep Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Mina Soufizomorrod (M)

Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, North Kargar Av, Tehran, 14117 Iran.

Saeid Abroun (S)

Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, North Kargar Av, Tehran, 14117 Iran.

Bahman Razi (B)

Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, North Kargar Av, Tehran, 14117 Iran.

Classifications MeSH